Celltrion Healthcare Co.,Ltd.
Hyunkyeong Yoo has extensive experience in market access and health economics and outcomes research (HEOR), currently serving as a Market Access & HEOR Manager at Celltrion Inc since March 2018, following roles as Global Marketing & Market Access Assistant Manager and Marketing Planning Specialist. Prior to this, Hyunkyeong held positions at Eli Lilly and Company as a BD Associate and at Celltrion Pharm Inc. as a Global BD Associate. Initial work experience includes internships at Noble Group in chartering and trading. Hyunkyeong completed a Bachelor’s degree in Spanish and Business Administration at Hankuk University of Foreign Studies from 2009 to 2015.
This person is not in the org chart
This person is not in any offices
Celltrion Healthcare Co.,Ltd.
Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines through an extensive global network that spans more than 110 different countries. Celltrion Healthcare provides REMSIMA, the world's first biosimilar monoclonal antibody (mAb) approved by the European Medicines Agency (EMA) for the treatment of autoimmune disease, and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world. For additional information on our guidelines, please visit: https://bit.ly/3QyOyt7